Tetracationic porphyrins inhibit angiogenesis induced by human tumor cellsin vivo

Citation
E. Izbicka et al., Tetracationic porphyrins inhibit angiogenesis induced by human tumor cellsin vivo, ANTICANC R, 20(5A), 2000, pp. 3205-3210
Citations number
18
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
ANTICANCER RESEARCH
ISSN journal
02507005 → ACNP
Volume
20
Issue
5A
Year of publication
2000
Pages
3205 - 3210
Database
ISI
SICI code
0250-7005(200009/10)20:5A<3205:TPIAIB>2.0.ZU;2-A
Abstract
Background: Cationic porphyrin TMPyP4, but not its isomer TMPyP2, inhibits telomerase in tumor cells in vitro and induces chromosome destabilization i n vivo. Materials and Methods: To examine the effects of these porphyrins o n tumor induced angiogenesis, 25-200 mug TMPyP4 or TMPyP2 were injected dai ly for 3 days in mice with intradermally implanted primary human tumor cell s. Alternatively tumor cells were exposed for 90 minutes to 2.5-20 muM porp hyrins prior to implantation in mice. Results: Either subcutaneous injectio ns (greater than or equal to 50 mug/mouse) ol preincubation with greater th an or equal to5 muM porphyrins significantly inhibited angiogenesis. Conclu sion: Antiangiogenic activity is apparently unrelated to the ability of the porphyrins to inhibit telomerase.